Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to clinical complete response

被引:0
|
作者
Suzuki, Shuhei [1 ]
Ito, Yuriko [1 ]
Fukui, Tadahisa [1 ]
Orihara, Mika [1 ]
Nakamura, Sho [1 ]
Takahashi, Masahiro [1 ]
Fujimoto, Hiroto [2 ]
Kimura, Wataru [2 ]
Yoshioka, Takashi [1 ]
机构
[1] Yamagata Univ, Yamagata Fac Med, Dept Clin Oncol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan
[2] Yamagata Univ, Yamagata Fac Med, Dept Surg 1, Yamagata, Japan
来源
INTERNATIONAL CANCER CONFERENCE JOURNAL | 2013年 / 2卷 / 04期
关键词
Gastric cancer; Clinical complete response; Cisplatin; S-1; Chemotherapy;
D O I
10.1007/s13691-013-0090-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin, leading to a clinical complete response (cCR). In case 1, a 60-year-old woman achieved a cCR after 6 cycles of S-1 and cisplatin. Eight cycles of S-1 and cisplatin and 16 cycles of S-1 alone were administered. Since treatment with S-1 alone, only observation has been performed with no recurrence. In case 2, a 63-year-old man achieved cCR after 2 cycles of S-1 and cisplatin chemotherapy. After 8 cycles of chemotherapy, cCR was confirmed, and a curative operation was performed. After surgery, a small number of viable cells were found in the pathological examination. Fifty-four reports of cCR cases of advanced non-resectable or metastatic gastric cancer with chemotherapy have been published, but none mentioned the treatment options after cCR. In this report, we show two patients choosing different paths after achieving cCR by chemotherapy. In our surgical case, residues of pathologically viable cancer cells were confirmed, so surgery might be recommended after cCR, but further investigation will be needed.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [21] Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation
    Takahashi, T
    Saikawa, Y
    Kubota, T
    Akiba, Y
    Shigematsu, N
    Yoshida, M
    Otani, Y
    Kumai, K
    Hibi, T
    Kitajima, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 584 - 588
  • [22] Complete response of a patient with advanced gastric cancer, showing Epstein-Barr virus infection, to preoperative chemotherapy with S-1 and cisplatin
    Tomoko Seya
    Noritake Tanaka
    Kimiyoshi Yokoi
    Noriyuki Ishikawa
    Koji Horiba
    Yoshikazu Kanazawa
    Takeshi Yamada
    Michihiro Koizumi
    Seiichi Shinji
    Hirotake Okazaki
    Yoshiharu Ohaki
    Toshiyuki Ishiwata
    Zenya Naito
    Takashi Tajiri
    International Journal of Clinical Oncology, 2007, 12 : 472 - 477
  • [23] Complete response of a patient with advanced gastric cancer, showing Epstein-Barr virus infection, to preoperative chemotherapy with S-1 and cisplatin
    Seya, Tomoko
    Tanaka, Noritake
    Yokoi, Kimiyoshi
    Ishikawa, Noriyuki
    Horiba, Koji
    Kanazawa, Yoshikazu
    Yamada, Takeshi
    Koizumi, Michihiro
    Shinji, Seiichi
    Okazaki, Hirotake
    Ohaki, Yoshiharu
    Ishiwata, Toshiyuki
    Naito, Zenya
    Tajiri, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (06) : 472 - 477
  • [24] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    Seiji Ito
    World Journal of Surgery, 2011, 35 : 470 - 471
  • [25] Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash
    John Spiliotis
    Odysseas Zoras
    World Journal of Surgery, 2011, 35 : 468 - 469
  • [26] An advanced gastric cancer with peritoneal dissemination: Complete response achieved with FLOT combination chemotherapy
    Hartono, Anita
    Lesmana, Tomy
    BALI MEDICAL JOURNAL, 2019, 8 (03) : S547 - S549
  • [27] Feasibility Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 for Advanced Gastric Cancer
    Fujitani, Kazumasa
    Hasegawa, Hiroko
    Hirao, Motohiro
    Kurokawa, Yukinori
    Tsujinaka, Toshimasa
    ANTICANCER RESEARCH, 2011, 31 (09) : 3085 - 3091
  • [28] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    D. Takahari
    T. Hamaguchi
    K. Yoshimura
    H. Katai
    S. Ito
    N. Fuse
    T. Kinoshita
    H. Yasui
    M. Terashima
    M. Goto
    N. Tanigawa
    K. Shirao
    T. Sano
    M. Sasako
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1423 - 1428
  • [29] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    British Journal of Cancer, 2007, 97 : 851 - 856
  • [30] A Phase I Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Kimura, Yutaka
    Yano, Hiroshi
    Imamura, Hiroshi
    Fujitani, Kazumasa
    Imano, Motohiro
    Tokunaga, Yukihiko
    Matsuoka, Masaki
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Takiuchi, Hiroya
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 125 - 131